2-Phenyl-1,3-propanediol-d4(98704-00-8)
- Name: 2-Phenyl-1,3-propanediol-d4
- Synonyms:2-Phenyl-1,3-propanediol-d4;2-Phenyl-1,3-propane-1,1,3,3-d4-diol;NSC 78023-d4
- Molecular Formula:C9H8D4O2
- Molecular Weight:156.215027112
- CAS Registry Number:98704-00-8
- EINECS:
- Melting Point:
- Water Solubility:
Other Product
- 67592-37-4/4-Cyclooctenyl Trimethoxysilane
- 5085-85-8/2-[(2E,5E,7E,9R,10R,11E)-10-hydroxy-3,7,9,11-tetramethyl-trideca-2,5,7,11-tetraenyl]-5,6-dimethoxy-3-methyl-1H-pyridin-4-one
- 62185-08-4/2,3,3,5-tetramethyl-4-ethylhexane
- 25882-59-1/3-(Ethylthio)-5-(methylthio)-4-isothiazolecarbonitrile
- 57688-18-3/p-(4-Chloro-m-tolyloxy)aniline
- 739302-29-5/Acetamide, N-[(3,4,5,6-tetrahydro-2H-azepin-7-yl)thio]-
- 769142-14-5/SALOR-INT L483443-1EA
- 1190392-19-8/ethyl 2-(4-methyl-6-oxopyridazin-1(6H)-yl)propanoate
- 63918-97-8/Lead styphnate
- 126594-75-0/(3β,5α,6α,16β)-8,14-didehydrocevane-3,6,16,20-tetrol.
- 5782-80-9/2-Aminooctadecanoic acid
- 24451-17-0/2-Amino-2-oxo-acetic acid, N-[3,4-dimethylphenyl]-, ethyl ester
- 98704-00-8/2-Phenyl-1,3-propanediol-d4
- 1090815-16-9/N-Cyclopropyl 4-chloropicolinaMide
- 1227626-51-8/Trityl olMesartan MedoxoMil iMpurity III
- 40760-02-9/N-[[4-(Dimethylamino)phenyl]methylene]-L-Trp-L-Met-L-αβAsp-(OEt)-L-Phe-NH2
- 156867-74-2/ART-CHEM-BB B018125
- 2894-44-2/2-CHLORO-2''-NITROBENZOPHENONE
- 928711-79-9/ASISCHEM C63536
- 765296-86-4/SALOR-INT L488615-1EA
- 937600-99-2/AKOS B030632
- 1788041-60-0/Methyl 2-(aminomethyl)pyrimidine-5-carboxylate hydrochloride
- 137682-88-3/1-hydroxycyclopropanecarboxamide
- 620941-98-2/Benzamide, 4-fluoro-N-(4,5,6,7-tetrahydro-4-benzofuranyl)- (9CI)
- 1142211-91-3/[{2-[4-(aminocarbonyl)piperidin-1-yl]-2-oxoethyl}(phenyl)amino]acetic acid
- 1313761-97-5/4-(Tetrahydro-2H-pyran-2-yl)methoxyphenylboronic acid
- 146924-92-7/(3S,4R)-3-Hydroxy-4-phenylazetidin-2-one
- 735269-73-5/CIS-3-(4-METHOXYBENZOYL)CYCLOHEXANE-1-CARBOXYLIC ACID
- 51230-91-2/2-(4-methoxyphenyl)pent-4-enoic acid
- 1286755-08-5/4H-5-Thia-1,6a-diaza-pentalene-3-carboxylic acid
